Cargando…
Resolution of chronic migraine headaches with intrathecal ziconotide: a case report
BACKGROUND: Migraine headaches are a common and functionally debilitating disorder affecting approximately 17% of women and 5.6% of men. Compared to episodic migraine patients, chronic migraineurs are more likely to be occupationally disabled, miss family activities, have comorbid anxiety and/or chr...
Autores principales: | Narain, Sachin, Al-Khoury, Lama, Chang, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573200/ https://www.ncbi.nlm.nih.gov/pubmed/26392785 http://dx.doi.org/10.2147/JPR.S84771 |
Ejemplares similares
-
Intrathecal Administration of Ziconotide as a Potential Treatment for Chronic Migraines
por: Holden, Ryan, et al.
Publicado: (2022) -
Near-resolution of persistent idiopathic facial pain with low-dose lumbar intrathecal ziconotide: a case report
por: Staub, Brandon P, et al.
Publicado: (2019) -
Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain
por: Smith, Howard S, et al.
Publicado: (2009) -
Intrathecal pain management with ziconotide: Time for consensus?
por: Matis, Georgios, et al.
Publicado: (2021) -
Intrathecal Ziconotide: Dosing and Administration Strategies in Patients With Refractory Chronic Pain
por: McDowell, Gladstone C., et al.
Publicado: (2016)